(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 5.01%995.17M | -9.08%1.83B | -13.36%947.68M | -21.40%2.01B | -15.26%1.09B | 40.79%2.56B | 68.75%1.29B | 42.03%1.82B | 37.41%764.91M | 42.15%1.28B |
Operating income | 5.01%995.17M | -9.08%1.83B | -13.36%947.68M | -21.40%2.01B | -15.26%1.09B | 40.79%2.56B | 68.75%1.29B | 42.03%1.82B | 37.41%764.91M | 42.15%1.28B |
Cost of sales | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -23.20%-546.36M | -39.49%-1.05B |
Operating expenses | -4.02%-755.43M | -0.19%-1.38B | 5.01%-726.21M | 18.91%-1.37B | 9.08%-764.5M | -31.64%-1.69B | -53.90%-840.84M | -22.65%-1.29B | -23.20%-546.36M | -39.49%-1.05B |
Gross profit | 8.24%239.74M | -28.89%456.88M | -32.74%221.48M | -26.24%642.47M | -26.82%329.3M | 62.75%871.01M | 105.89%449.98M | 128.92%535.17M | 93.14%218.55M | 55.46%233.78M |
Selling expenses | 22.27%-2.82M | -14.26%-8.19M | -12.29%-3.62M | 66.55%-7.17M | 61.66%-3.23M | -118.77%-21.44M | -204.95%-8.41M | -353.10%-9.8M | -377.34%-2.76M | -96.99%-2.16M |
Administrative expenses | 4.25%-56.66M | 23.10%-131.87M | 25.52%-59.17M | 6.30%-171.5M | 23.32%-79.45M | -18.95%-183.03M | -25.39%-103.61M | -31.96%-153.87M | -70.52%-82.64M | -57.09%-116.61M |
Research and development expenses | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | ---- |
Profit from asset sales | --260.03K | ---58.86K | ---- | ---- | ---10.1K | -45.70%6.15K | --0 | --11.33K | ---- | ---- |
Revaluation surplus | -153.52%-13.38K | -152.86%-328.86K | 100.55%25K | -86.00%622.17K | -637.95%-4.58M | 71.96%4.45M | ---620.1K | --2.59M | ---- | ---- |
-Changes in the fair value of other assets | -153.52%-13.38K | -152.86%-328.86K | 100.55%25K | -86.00%622.17K | -637.95%-4.58M | 71.96%4.45M | ---620.1K | --2.59M | ---- | ---- |
Impairment and provision | -69.98%-59.86M | -10.86%-157.42M | -5.52%-35.21M | 2.89%-142M | -149.87%-33.37M | -1,412.20%-146.23M | -98.39%-13.36M | -197.02%-9.67M | -1,537.96%-6.73M | 357.48%9.97M |
-Other impairment is provision | -69.98%-59.86M | -10.86%-157.42M | -5.52%-35.21M | 2.89%-142M | -149.87%-33.37M | -1,412.20%-146.23M | -98.39%-13.36M | -197.02%-9.67M | -1,537.96%-6.73M | 357.48%9.97M |
Operating interest expense | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | ---- |
Special items of operating profit | -81.55%1.95M | 337.55%9.19M | -60.56%10.59M | -115.81%-3.87M | 496.37%26.86M | 252.73%24.47M | -78.47%4.5M | -82.97%6.94M | 35.05%20.92M | 11.25%40.74M |
Operating profit | -9.60%117.15M | -48.32%158.72M | -43.57%129.6M | -42.16%307.15M | -30.08%229.66M | 49.53%531.04M | 122.93%328.48M | 114.31%355.13M | 86.04%147.35M | 53.72%165.71M |
Financing income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -89.23%1.86M | -128.88%-13.15M |
Financing cost | 173.96%569.57K | -52.01%10.01M | -103.81%-770.11K | 365.56%20.85M | 796.03%20.2M | -222.52%-7.85M | 174.66%2.25M | --6.41M | 87.59%-3.02M | ---- |
Special items of earning before tax | 250.71%1.98M | 20.37%-2.07M | -43.69%-1.32M | -130.96%-2.6M | 54.87%-915.41K | 34.20%-1.13M | ---2.03M | ---1.71M | ---- | ---- |
Earning before tax | -6.12%119.7M | -48.78%166.66M | -48.78%127.51M | -37.67%325.4M | -24.26%248.95M | 45.08%522.06M | 124.85%328.7M | 135.85%359.83M | 102.58%146.19M | 52.17%152.57M |
Tax | -7.58%-26.94M | 54.94%-35.97M | 61.90%-25.04M | 35.89%-79.82M | 19.31%-65.72M | -29.59%-124.51M | -96.88%-81.45M | -143.79%-96.08M | -114.63%-41.37M | -41.10%-39.41M |
After-tax profit from continuing operations | -9.47%92.77M | -46.78%130.69M | -44.07%102.47M | -38.23%245.58M | -25.90%183.22M | 50.73%397.55M | 135.89%247.25M | 133.09%263.76M | 98.19%104.82M | 56.44%113.16M |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
Earning after tax | -9.47%92.77M | -46.78%130.69M | -44.07%102.47M | -38.23%245.58M | -25.90%183.22M | 50.73%397.55M | 135.89%247.25M | 133.09%263.76M | 98.19%104.82M | 56.44%113.16M |
Minority profit | 38.54%1.67M | 26.56%4.36M | 65.81%1.2M | 345.64%3.45M | 21,176.27%725.95K | ---1.4M | --3.41K | --0 | ---- | -217.46%-74K |
Profit attributable to shareholders | -10.04%91.1M | -47.83%126.33M | -44.51%101.27M | -39.31%242.13M | -26.19%182.5M | 51.26%398.95M | 135.89%247.25M | 132.93%263.76M | 97.82%104.82M | 56.68%113.23M |
Basic earnings per share | -11.11%0.24 | -46.88%0.34 | -44.90%0.27 | -39.62%0.64 | -26.87%0.49 | 9.28%1.06 | 67.50%0.67 | 120.45%0.97 | 90.48%0.4 | 57.14%0.44 |
Diluted earnings per share | -11.11%0.24 | -46.88%0.34 | -44.90%0.27 | -39.62%0.64 | -26.87%0.49 | 9.28%1.06 | 67.50%0.67 | 120.45%0.97 | 90.48%0.4 | 57.14%0.44 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Shinaga Chuwa Certified Public Accountants | -- | Shinaga Chuwa Certified Public Accountants | -- | Shinaga Chuwa Certified Public Accountants | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data